Effect of Nebivolol on Survival of Cardiomyopathic Hamsters with Congestive Heart Failure

[1]  M. Borgers,et al.  Nebivolol Increases Survival in Cardiomyopathic Hamsters with Congestive Heart Failure , 1991, Journal of cardiovascular pharmacology.

[2]  H. Verhaegen,et al.  Comparison of the Subacute Hemodynamic Effects of Atenolol, Propranolol, Pindolol, and Nebivolol , 1990, Angiology.

[3]  R. Hubert,et al.  Effects of milrinone treatment in cardiomyopathic hamsters (CHF 147) with severe congestive heart failure. , 1989, Cardiovascular research.

[4]  J. V. van Meel,et al.  Pimobendan Increases Survival of Cardiomyopathic Hamsters , 1989, Journal of cardiovascular pharmacology.

[5]  E. Sonnenblick,et al.  Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy. , 1988, Journal of the American College of Cardiology.

[6]  R. Reneman,et al.  Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. , 1988, Journal of cardiovascular pharmacology.

[7]  H R Figulla,et al.  Inhomogenous capillary flow and its prevention by verapamil and hydralazine in the cardiomyopathic Syrian hamster. , 1987, Circulation.

[8]  E. Sonnenblick,et al.  Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. , 1985, The American journal of cardiology.

[9]  G. Jasmin,et al.  Calcium and myocardial cell injury. An appraisal in the cardiomyopathic hamster. , 1984, Canadian journal of physiology and pharmacology.

[10]  E. Sonnenblick,et al.  Microvascular Spasm in the Cardiomyopathic Syrian Hamster: A Preventable Cause of Focal Myocardial Necrosis , 1982, Circulation.

[11]  B. Solymoss,et al.  THERAPEUTIC TRIALS IN HAMSTER DYSTROPHY * , 1979, Annals of the New York Academy of Sciences.

[12]  B. Solymoss,et al.  Prevention of Hereditary Cardiomyopathy in the Hamster by Verapamil and Other Agents 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[13]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[14]  E. Bajusz,et al.  New models of human disease in Syrian hamsters. , 1970, JAMA.

[15]  J. R. Baker,et al.  DISSOCIATION OF FACTORS INFLUENCING MYOCARDIAL DEGENERATION AND GENERALIZED CARDIOCIRCULATORY FAILURE * , 1969, Annals of the New York Academy of Sciences.

[16]  J. R. Baker,et al.  SPONTANEOUS, HEREDITARY MYOCARDIAL DEGENERATION AND CONGESTIVE HEART FAILURE IN A STRAIN OF SYRIAN HAMSTERS * , 1969, Annals of the New York Academy of Sciences.